VOLUNTARY ANNOUNCEMENT - Admission of the SureCham TM Aortic Arch Single-Branch Stent Graft System into Special Examination and Approval Procedure for Innovative Medical Devices
Filed with HKEX · Stock code 1302 · · 3 pages · English
LifeTech Scientific Corporation先健科技公司 (Incorporated in the Cayman Islands with limited liability) (Stock code: 1302) VOLUNTARY ANNOUNCEMENT Admission of the SureCham™ Aortic Arch Single-Branch ## Stent Graft System into Special Examination and Approval ## Procedure for Innovative Medical Devices This announcement is made by LifeTech Scientific Corporation (the “Company”, together with its subsidia
LifeTech Scientific Corporation on 6ix
Earlier from LifeTech Scientific
- LifeTech Scientific Corporation Announces 2026 Interim Results
- LifeTech Scientific Corporation Announces 2025 Annual Results: Steady Revenue Growth with Adjusted Net Profit Increasing 24.9%
- LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased
- LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%
- LifeTech Scientific Corporation Announced 2024 Interim Results: International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%
Later from LifeTech Scientific
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- VOLUNTARY ANNOUNCEMENT - Admission of the ICS Elpis Bioresorbable Peripheral Balloon-Expandable Covered Scaffold System into Special Examination and Approval Procedure for Innovative Medical Devices
Follow LifeTech Scientific into a list and get an email when it puts out news.
Follow LifeTech Scientific